摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-bis(iodomethyl)-5-methyl-benzene | 90678-51-6

中文名称
——
中文别名
——
英文名称
1,3-bis(iodomethyl)-5-methyl-benzene
英文别名
1,3-Bis(iodomethyl)-5-methylbenzene
1,3-bis(iodomethyl)-5-methyl-benzene化学式
CAS
90678-51-6
化学式
C9H10I2
mdl
——
分子量
371.987
InChiKey
YIWKKYWOXUVLRE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    三价1,3,5-三亚甲基苯的分离与表征
    摘要:
    首次分离出高度对称的四元基三自由基三亚甲基苯(参见结构)。尽管它具有开壳特性,但它在光化学上是稳定的,这使其成为磁性材料的有前途的构建基块。
    DOI:
    10.1002/anie.201001393
点击查看最新优质反应信息

文献信息

  • Process for the Preparation of 2,2'-[5-(1H-1,2,4-Triazole-1-Ylmethyl) -1,3-Phenylene] Di (2-Methylpropionitrile)
    申请人:Radhakrishnan Tarur Venkatasubramanian
    公开号:US20080207915A1
    公开(公告)日:2008-08-28
    The present invention discloses a process for the preparation of Anastrozole of the formula I in high purity and in high yield. 3,5-bis(halomethyl)toluene is prepared by reacting mesitylene with N-halosuccinimide in the presence of light or dibenzoyl peroxide or azobis isobutyronitrile as a catalyst and in a chlorinated solvent. 3,5-bis(halomethyl)toluene is cyanated with metal cyanide in the presence of a catalyst and in water, organic solvent or mixture thereof at temperature of 40 to 60° C. to obtain 2,2′-(5-methyl-1,3 phenylene)diacetonitrile which is further methylated with iodomethane in the presence of base and an organic solvent at temperature of 0 to 15° C. to obtain 2,2′-(5-methyl-1,3-phenylene)di(2-methyl-propiononitrile). The product obtained is treated with N-halosuccinimide in the presence of a catalyst and in a chlorinated solvent at temperature of 60 to 100° C. to obtain 2,2′-(5-halomethyl-1,3-phenylene)di(2-methyl propionitrile) which was further treated with potassium or sodium salt 1,2,4-triazole at temperature of 20 to 50° C. in dimethyl formamide to obtain crude 2,2′-[5-( 1 H-1,2,4-triazole-1-ylmethyl)-1,3-phenylene]di(2-methyl-propionitrile). The crude product is purified by column chromatography using a stationary phase and a mobile phase followed by recrystallization with a solvent or mixture of solvents to obtain highly pure Anastrozole.
    本发明揭示了一种制备高纯度和高产率的化学式I的阿那曲唑的方法。首先,通过将间二甲苯与N-卤代琥珀酰亚胺在光照或二苯甲酰过氧化物或异丁腈偶氮叔丁酰胺存在下在化溶剂中反应制备3,5-双(卤甲基)甲苯。然后,在催化剂的存在下,将3,5-双(卤甲基)甲苯化物在、有机溶剂或二者混合物中在40至60°C的温度下反应,得到2,2′-(5-甲基-1,3-苯基)双乙腈。接着,在碱和有机溶剂存在下,在0至15°C的温度下,将2,2′-(5-甲基-1,3-苯基)双乙腈碘甲烷反应甲基化,得到2,2′-(5-甲基-1,3-苯基)双(2-甲基-丙酰亚胺)。随后,将所得产物在催化剂的存在下,在60至100°C的温度下,与N-卤代琥珀酰亚胺化溶剂中反应,得到2,2′-(5-卤甲基-1,3-苯基)双(2-甲基丙腈)。最后,将该产物与盐或钠盐1,2,4-三唑在20至50°C的温度下在二甲基甲酰胺中反应,得到粗的2,2′-[5-(1H-1,2,4-三唑-1-基甲基)-1,3-苯基]双(2-甲基丙腈)。通过柱层析和再结晶,使用固定相和流动相纯化粗产品,最终获得高纯度的阿那曲唑
  • NITROGEN-CONTAINING FUSED RING COMPOUND AND USE THEREOF
    申请人:Japan Tobacco, Inc.
    公开号:EP1820515A1
    公开(公告)日:2007-08-22
    A URAT1 activity inhibitor containing a nitrogen-containing fused ring compound represented by the following formula [1]: wherein each symbol is as defined in the description. The present invention is useful for the prophylaxis or treatment of pathology showing involvement of uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urolithiasis, renal function disorder, coronary artery disease, ischemic heart disease and the like.
    一种 URAT1 活性抑制剂,含有下式[1]代表的含氮融合环化合物: 其中各符号如描述中所定义。本发明可用于预防或治疗尿酸参与的病变,如高尿酸血症、痛风性头痛、急性痛风性关节炎、慢性痛风性关节炎、痛风性肾、尿路结石、肾功能紊乱、冠状动脉疾病、缺血性心脏病等。
  • [EN] PROCESS FOR THE PREPARATION OF 2,2'-[5-(1,2,4-TRIAZOLE-1-YLMETHYL) -1,3-PHENYLENE] DI (2-METHYLPROPIONITRILE).<br/>[FR] PROCEDE DE PREPARATION DE 2,2'-[5-(1,2,4-TRIAZOLE-1-YLMETHYL)-1,3-PHENYLENE]DI(2-METHYLPROPIONITRILE).
    申请人:USV LTD
    公开号:WO2007039913A1
    公开(公告)日:2007-04-12
    [EN] The present invention discloses a process for the preparation of Anastrozole of the formula I in high purity and in high yield. 3,5-bis(halomethyl)toluene is prepared by reacting mesitylene with N-halosuccinimide in the presence of light or dibenzoyl peroxide or azobis isobutyronitrile as a catalyst and in a chlorinated solvent. 3,5-bis(halomethyl)toluene is cyanated with metal cyanide in the presence of a catalyst and in water, organic solvent or mixture thereof at temperature of 40 to 60° C to obtain 2,2'-(5-methyl-l,3 phenylene)diacetonitrile which is further methylated with iodomethane in the presence of base and an organic solvent at temperature of 0 to 15° C to obtain 2,2'-(5-methyl-l,3-phenylene)di(2-methyl-propiononitrile). The product obtained is treated with N-halosuccinimide in the presence of a catalyst and in a chorinated solvent at temperature of 60 to 100° C to obtain 2,2'-(5-halomethyl-l,3-phenylene)di(2-methyl propionitrile) which was further treated with potassium or sodium salt 1,2,4-triazole at temperature of 20 to 50° C in dimethyl formamide to obtain crude 2,2'-[5-(lH-l,2,4-triazole-l-ylmethyl)-l,3-phenylene]di(2- methylpropionitrile). The crude product is purified by column chromatography using a stationary phase and a mobile phase followed by recrystallization with a solvent or mixture of solvents to obtain highly pure Anastrozole.
    [FR] L'invention concerne un procédé permettant de préparer un anastrozole représenté par la formule (I) à pureté et à rendement élevés. On prépare un 3,5-bis(halomethyl)toluène par réaction d'un mésitylène avec N-halosuccinimide en présence de lumière ou d'un peroxyde de dibenzoyle ou d'un azobis-isobutyronitrile utilisé comme catalyseur et dans un solvant chloré. Ledit 3,5-bis(halomethyl)toluène est cyanaté au moyen d'un cyanure de métal en présence d'un catalyseur et dans l'eau, d'un solvant organique ou d'un mélange des éléments précités à une température comprise entre 40 et 60° C afin d'obtenir un 2,2'-(5-methyl-1,3 phenylene)diacétonitrile qui est ensuite méthylé au moyen d'un iodométhane en présence d'une base et d'un solvant organique à une température comprise entre 0 et 15° C afin d'obtenir un 2,2'-(5-methyl-1,3-phenylene)di(2-methyl-propiononitrile). Le produit obtenu est traité à l'aide d'un N-halosuccinimide en présence d'un catalyseur dans un solvant chloré à une température comprise entre 60 et 100° C afin d'obtenir un 2,2'-(5-halomethyl-1,3-phenylene)di(2-methyl propionitrile) qui est ensuite traité par un 1,2,4-triazole de sel de potassium ou sodium à une température comprise entre 20 et 50° C dans un diméthyle formamide afin d'obtenir un 2,2'-[5-(lH-l,2,4-triazole-1-ylmethyl)-l,3-phenylene]di(2- methylpropionitrile) brut. Le produit brut est purifié par chromatographie sur colonne à l'aide d'une phase fixe et d'une phase mobile suivies d'une recristallisation avec un solvant ou un mélange de solvants afin d'obtenir un anastrozole très pur.
  • [EN] FAP INHIBITORS<br/>[FR] INHIBITEURS FAP
    申请人:FERRING BV
    公开号:WO2007085895A2
    公开(公告)日:2007-08-02
    [EN] The present invention concerns compounds, which find utility, preferably for the treatment of cancer.
    [FR] La présente invention concerne des composés qui sont utiles, de préférence, dans le traitement de cancers.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫